España
India
Italia
대한민êµ
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Recent
Markets
Shaul Eyal
What Crowdstrike Analysts Are Saying After Q1 Beat: 'A Unique Investment Vehicle'
Analysts Cautious On LogMeIn: 'The Stock Will Likely Remain A 'Show Me' Story'
The Street Reaction To Splunk's Q2
Analysts Cautious On LogMeIn: 'The Stock Will Likely Remain A 'Show Me' Story'
The Street Reaction To Splunk's Q2
Oppenheimer Downgrades Intellicheck After Q2 Revenue Miss
Oppenheimer: Nuance Communications Rebounding From Recent Cyberattack
Oppenheimer Downgrades Intellicheck After Q2 Revenue Miss
|
Oppenheimer: Nuance Communications Rebounding From Recent Cyberattack
|
After Q3, Patience Is A Virtue For FireEye Investors
|
FireEye Had A Great Quarter, But Long-Term Questions Remain
|
Read More...
Shaul Eyal Recent News
Symantec's LifeLock Purchase Could Reinvigorate Consumer Division
|
4 Keys From Check Point Software's Recent Investor Meetings
|
Set Up Into FireEye's Earnings Report 'Remains Attractive'
|
Oppenheimer Reiterates Outperform, $35 Target On FireEye, Sees Positive Momentum As Intact
|
The Street Likes FireEye, But 2016 Will Be A Pivotal Year
|
Oppenheimer Sees $196 For Palo Alto Networks After Meeting With Management
|
Oppenheimer: 'Never Say Never' On Check Point-CyberArk M&A, But Probability Low
|
Cyberark Spikes 18% Following Merger Chatter; Oppenheimer Assigns 'Low Probability' On Transaction
|
These Two Analysts Remain Bullish On Verint Following Its Q3 Print
|
35 Stock Ideas Oppenheimer Analysts Love Right Now
|
Oppenheimer Upgrades FireEye On 'Clearer Path To Profitability'
|
Small-Cap Software Provider Comverse Expected To Report Considerable Growth
|
Splunk Expected To Report Slight EPS Growth On Considerable Revenue Increase
|
Check Out Oppenheimer's Take On Software, Cybersecurity
|
Wall Street Still Likes Palo Alto Networks
|
Analysts On Palo Alto Networks: 'More Wood To Be Chopped'
|
UPDATE: Oppenheimer Initiates Coverage On CyberArk Software Ltd On Bullish Stance
|
UPDATE: Oppenheimer Reiterates On Palo Alto Networks As Checks Indicate Solid Close To FY14
|
Nuance Goes Higher As Bullish Analysts Chime In Following Rumor
|
UPDATE: Oppenheimer Upgrades Amdocs, Safe-Haven Investment Vehicle in Uncertain Market
|
UPDATE: Oppenheimer Initiates Coverage on Splunk on Multiple Positive Factors
|
UPDATE: Oppenheimer Initiates Splunk On Recent Rapid Growth
|
Oppenheimer Sees Departure of Fortinet CFO/COO Ahmad Rubaie as a Near-Term Negative
|